Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Carlsbad, CA
SEC filing record 1 source field available
Fiscal year end
31 December
IONIS PHARMACEUTICALS INC has filed 2,665 SEC EDGAR filings since 12 Jun 1996

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page
25
Current page
38
4

PRIMARY DOCUMENT

Filing date
30 Nov 2020
Reporting date
25 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Nov 2020
Reporting date
25 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Nov 2020
Reporting date
25 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Nov 2020
Reporting date
25 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Nov 2020
Reporting date
23 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Nov 2020
Reporting date
23 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Nov 2020
Reporting date
23 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Nov 2020
Reporting date
23 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Nov 2020
Reporting date
03 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-19125

IONIS PHARMACEUTICALS INC 10-Q 9-30-2020

Filing date
04 Nov 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Oct 2020
Reporting date
20 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Oct 2020
Reporting date
15 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Oct 2020
Reporting date
15 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38137

FORM 4 SUBMISSION

Filing date
14 Oct 2020
Reporting date
10 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
13 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
13 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
02 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-41771

SC 13G/A filing

Filing date
02 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
30 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
29 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
24 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Sep 2020
Reporting date
21 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .